Search

everythinglearnresearchcommunity

for

Search:↓

The project created a standardized system for classifying skin lesions in lab rats and mice.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

In vitro skin models are improving but still need more innovation to fully replicate human skin.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Curcumin can protect against mercury's harmful effects on brain and behavior.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Women with hair loss may benefit from higher iron levels.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

The document concludes that compulsive hair disorders, like trichotillomania, are complex and require careful diagnosis and treatment from both psychiatric and dermatological perspectives.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The herbal shampoo with fermented rice water is safe and effective for reducing hair fall.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Endoscopic brow-lift is effective and well-tolerated, with high patient satisfaction and improved appearance.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

Early hair greying may increase the risk of heart disease.

PCOS is a hormonal disorder affecting many women, leading to symptoms like acne and irregular periods, and increasing the risk of diabetes and heart disease.

Hair loss in alopecia areata can negatively affect sexual quality of life.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.